India's drug standards delay raises worries over reputation, quality

RAJASTHAN, India -- India has given small and midsize drug manufacturers another year to comply with international standards, a move that experts say further dents the reputation of an industry whose products have been linked to deaths across the world. New Delhi said last month it would delay to…